Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler(®) Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study

Background: Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory lung disease characterized by airflow limitation that is not completely reversible. The fixed-dose combination of salmeterol and fluticasone propionate (SFC) has been approved as a treatment for COPD patients with a history...

Descripción completa

Detalles Bibliográficos
Autores principales: Steiropoulos, Paschalis, Tryfon, Stavros, Kyriakopoulos, Christos, Bartziokas, Konstantinos, Kostikas, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621702/
https://www.ncbi.nlm.nih.gov/pubmed/34834511
http://dx.doi.org/10.3390/jpm11111159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621702/
https://www.ncbi.nlm.nih.gov/pubmed/34834511
http://dx.doi.org/10.3390/jpm11111159

Ejemplares similares